Top Stories

HHS invests $480 million in Cue Health to boost manufacturing of rapid coronavirus test


The U.S. is investing $481 million in California-based start-up Cue Health to boost manufacturing of its coronavirus test that produces results in about 20 minutes and without needing to be processed at a lab, U.S. agencies announced Tuesday.

Cue, which is backed by Johnson and Johnson among other investors, will increase production to 100,000 test kits per day by March, according to the Department of Health and Human Services. It added that the U.S. will acquire 6 million tests and 30,000 lab instruments used to process the tests.

“Cue’s tests provide results in about 20 minutes with the kind of accuracy provided by lab tests that can take several days, adding to our dramatically…


Treasury yields fall as traders weigh U.S. coronavirus stimulus prospects

Previous article

Alaska Air forecasts 40% capacity cuts in Q4, more cuts into 2021

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories